biotech – Page 4

Newswire

[ March 27, 2024 ] Snow Lake (NASDAQ: LTIM) Initiates 2024 Exploration Program at Engo Valley Uranium Project Mining & Metals
[ February 26, 2024 ] Snow Lake (NASDAQ: LITM)Transformational Acquisition of the Highly Prospective Engo Valley Uranium Project, Namibia Mining & Metals
[ February 13, 2024 ] Snow Lake (NASDAQ: LITM) Expands Its Lithium Portfolio with Mineral Claims near Kenora, Ontario Mining & Metals
[ January 16, 2024 ] Appia (OTC: APAAF) Reports 92,758 ppm (9.3%) TREO, 13,798 ppm MREO (1.38%) and 2,241 (.24%) ppm HREO over 2m Within the Total Weighted Average of 38,655 ppm (3.87%) TREO, 6,869 ppm (.69%) MREO, and 1,380 ppm (.14%) HREO Across 24m (EOH) Following the Reanalysis of Over-Limit Assay Results from PCH-RC-063 at the PCH Ionic Adsorption Clay Project in Goias, Brazil Mining & Metals
[ January 15, 2024 ] Appia (OTC: APAAF) Announces Significant Geochemical Critical REE Assay Results at Alces Lake Project, Saskatchewan, Canada Mining & Metals
[ January 12, 2024 ] Appia Receives Approval for 12 Additional Claim Blocks at Its PCH Rare Earths Ionic Adsorption Clay Project, Goias, Brazil Mining & Metals
[ January 12, 2024 ] Snow Lake Lithium (NASDAQ: LITM) CEO Update to Shareholders Mining & Metals
[ December 21, 2023 ] Snow Lake (NASDAQ: LITM) Expands Its Lithium Portfolio with Mineral Claims Next to the Tanco Mine Mining & Metals
[ December 18, 2023 ] Appia (OTC: APAAF) Announces Non-Brokered Flow-Through Private Placement Mining & Metals
[ December 13, 2023 ] Appia (OTC: APAAF) Announces Scandium and Cobalt Discovery at Its New Buriti Target at the PCH Project, Brazil; Reverse Circulation Drill Hole Returns 24 Metres of Mineralization Averaging 128 ppm Scandium Oxide, 272 ppm Total Cobalt Oxides and 2,106 ppm Total Rare Earth Oxides from Surface Mining & Metals

CEO Interview

BrainStorm Cell Therapeutics (NASDAQ: BCLI) Stem cell therapy for ALS in Phase III FDA trials

December 23, 2018 admin Comments Off

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI) interview with CEO, Chaim Lebovits, discussing the company’s advancements in developing stem cell therapies to treat neurodegenerative diseases. The company’s pipeline includes a lead indication for ALS- Amyotrophic Lateral […]

Nexien BioPharma, Inc (OTC: NXEN) Developing a cannabinoid-based drug pipeline.

November 14, 2018 admin Comments Off

Nexien BioPharma, Inc (OTC: NXEN) CEO Interview with Alex Wasyl discussing the company’s cannabinoid-based drug development pipeline. Drug development targets include, epliepsy, myotonia and other markets.

FSD Pharma, Inc (CSE: HUGE) (OTC: FSDDF) Building world’s largest indoor cannabis grower.

November 13, 2018 admin Comments Off

FSD Pharma, Inc (CSE: HUGE) (OTC: FSDDF) CEO Interview with Dr. Raza Bokhari. FSD Pharma is building the worlds largest licensed indoor cannabis growing facility […]

Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., discusses cannabinoid-based drug pipeline.

October 17, 2018 admin Comments Off

Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., shares update on Tetra’s Cannabinoid-based drug pipeline as opioid alternative. Investor Presentation Deck

Healthcare

Pulmatrix (NASDAQ: PULM) Investor Presentation

October 8, 2018 admin Comments Off

Pulmatrix (NASDAQ: PULM) Investor Presentation 9/5/2018

The $TRILLION Opportunity in CRISPR & DNA Sequencing Technologies

July 16, 2018 admin Comments Off

Cathie Wood, of ARK Genomic Revolution ETF(NYSE: ARKG) explains the multi-trillion dollar opportunity in the Genomics Revolution: CAR-T, CRISPR, and DNA Sequencing

Check-Cap (NASDAQ: CHEK) Announces Pricing of $17.5 Million Upsized Underwritten Public Offering

May 5, 2018 admin Comments Off

ISFIYA, Israel, May 04, 2018 — Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK, CHEKW, CHEKZ), a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free, colorectal cancer screening, […]

Abeona Therapeutics (NASDAQ:ABEO) Receives Orphan Drug Designation in the European Union for ABO-202 Gene Therapy Program in Batten Disease

April 20, 2018 admin Comments Off

NEW YORK and CLEVELAND, April 20, 2018 – Abeona Therapeutics Inc. (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, announced today that the European […]